EuroIntervention PCRonline - Connecting with the community

Just accepted article

Three-Year Safety and Efficacy of Treating All-Comers With Newer-Generation Resolute Integrity or Promus Element Stents in the Randomised DUTCH PEERS (TWENTE II) Trial


As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

1. Thoraxcentrum Twente, Enschede; 2. Thoraxcentrum Twente, Enschede; 3. Thoraxcentrum Twente, Enschede; 4. Rijnstate Hospital, Arnhem; 5. Treant Zorggroep, location Emmen; 6. Medical Center Alkmaar, Alkmaar; 7. Thoraxcentrum Twente, Enschede; 8. Thoraxcentrum Twente, Enschede; 9. Thoraxcentrum Twente, Enschede; 10. Ziekenhuisgroep Twente, Almelo and Hengelo; 11. Department of Health Technology and Services research, MIRA - Institue for Biomedical Technology and Technical Medicine, University of Twente, Enschede; 12. Thoraxcentrum Twente & University of Twente, Cardiology Department, Enschede, NETHERLANDS


Aims: To assess the 3-year safety and efficacy of implanting newer-generation Resolute Integrity zotarolimus-eluting stents (ZES) versus Promus Element everolimus-eluting stents (EES) in all-comers.

Methods and results: In the randomised, …

– OR –